Published in J Proteomics on October 16, 2010
SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1. Nature (2015) 2.01
The Human Eye Proteome Project: perspectives on an emerging proteome. Proteomics (2013) 1.23
A reversible gene trap collection empowers haploid genetics in human cells. Nat Methods (2013) 1.17
Functional dissection of the TBK1 molecular network. PLoS One (2011) 1.16
Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity. Cell (2016) 1.10
CD4(+) T cell lineage integrity is controlled by the histone deacetylases HDAC1 and HDAC2. Nat Immunol (2014) 1.05
Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia. Nat Chem Biol (2015) 0.96
Characterizing the normal proteome of human ciliary body. Clin Proteomics (2013) 0.90
In-depth mass spectrometric mapping of the human vitreous proteome. Proteome Sci (2013) 0.86
Autotaxin-lysophosphatidic acid axis is a novel molecular target for lowering intraocular pressure. PLoS One (2012) 0.85
Proteomics of vitreous humor of patients with exudative age-related macular degeneration. PLoS One (2014) 0.85
Affinity purification strategies for proteomic analysis of transcription factor complexes. J Proteome Res (2013) 0.85
Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth. Leukemia (2015) 0.85
A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung Adenocarcinoma. PLoS One (2015) 0.85
A miniaturized chemical proteomic approach for target profiling of clinical kinase inhibitors in tumor biopsies. J Proteome Res (2013) 0.81
Identification of kinase inhibitor targets in the lung cancer microenvironment by chemical and phosphoproteomics. Mol Cancer Ther (2014) 0.80
abFASP-MS: affinity-based filter-aided sample preparation mass spectrometry for quantitative analysis of chemically labeled protein complexes. J Proteome Res (2014) 0.77
Modeling approach to characterize intraocular doripenem pharmacokinetics after intravenous administration to rabbits, with tentative extrapolation to humans. Antimicrob Agents Chemother (2012) 0.75
Transcriptomic and Proteomic Analysis of Arion vulgaris-Proteins for Probably Successful Survival Strategies? PLoS One (2016) 0.75
Characterization of the human aqueous humour proteome: A comparison of the genders. PLoS One (2017) 0.75
Expanding the Interactome of the Noncanonical NF-κB Signaling Pathway. J Proteome Res (2016) 0.75
Aqueous humor endothelin-1 and total retinal blood flow in patients with non-proliferative diabetic retinopathy. Eye (Lond) (2017) 0.75
Analysis of aqueous humor concentrations of cytokines in retinoblastoma. PLoS One (2017) 0.75
Morgagnian cataract resulting from a naturally occurring nonsense mutation elucidates a role of CPAMD8 in mammalian lens development. PLoS One (2017) 0.75
Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature (2002) 45.19
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (2006) 24.54
Proteome survey reveals modularity of the yeast cell machinery. Nature (2006) 20.77
Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med (2005) 12.64
Genesis: cluster analysis of microarray data. Bioinformatics (2002) 10.50
Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med (2013) 9.65
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics (2009) 8.60
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology (2012) 8.29
The minimum information required for reporting a molecular interaction experiment (MIMIx). Nat Biotechnol (2007) 8.24
An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol (2009) 7.93
A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol (2004) 7.23
ELM server: A new resource for investigating short functional sites in modular eukaryotic proteins. Nucleic Acids Res (2003) 6.86
The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology (2011) 6.33
Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol (2011) 5.63
Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell (2003) 5.44
Peroxisomes are signaling platforms for antiviral innate immunity. Cell (2010) 5.24
The CRAPome: a contaminant repository for affinity purification-mass spectrometry data. Nat Methods (2013) 4.34
Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21
IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. Nat Immunol (2011) 4.18
In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol (2009) 3.97
Generalized Venn diagrams: a new method of visualizing complex genetic set relations. Bioinformatics (2004) 3.77
A survey of tools for variant analysis of next-generation genome sequencing data. Brief Bioinform (2013) 3.60
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets. Blood (2007) 3.59
Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity (2013) 3.50
A myristoyl/phosphotyrosine switch regulates c-Abl. Cell (2003) 3.48
An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells. Nat Methods (2006) 3.38
Idiopathic multifocal choroiditis/punctate inner choroidopathy with acute photoreceptor loss or dysfunction out of proportion to clinically visible lesions. Retina (2015) 3.26
Target profiling of small molecules by chemical proteomics. Nat Chem Biol (2009) 3.20
Regulation of the c-Abl and Bcr-Abl tyrosine kinases. Nat Rev Mol Cell Biol (2004) 3.10
CARMAweb: comprehensive R- and bioconductor-based web service for microarray data analysis. Nucleic Acids Res (2006) 2.93
Structure-based assembly of protein complexes in yeast. Science (2004) 2.89
Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature (2011) 2.64
A chemical and phosphoproteomic characterization of dasatinib action in lung cancer. Nat Chem Biol (2010) 2.53
The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib. Proc Natl Acad Sci U S A (2007) 2.51
Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration. Ophthalmology (2005) 2.51
Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation. Cell (2008) 2.46
Rediscovering the sweet spot in drug discovery. Drug Discov Today (2003) 2.45
NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol (2009) 2.39
Coordination of intratumoral immune reaction and human colorectal cancer recurrence. Cancer Res (2009) 2.37
miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging. Aging Cell (2010) 2.31
The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema. Ophthalmology (2011) 2.29
Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase. Mol Cell (2006) 2.28
One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema. Ophthalmology (2012) 2.20
Retinal pigment epithelium segmentation by polarization sensitive optical coherence tomography. Opt Express (2008) 2.18
MARS: microarray analysis, retrieval, and storage system. BMC Bioinformatics (2005) 2.14
RhoB and actin polymerization coordinate Src activation with endosome-mediated delivery to the membrane. Dev Cell (2004) 2.13
PathwayExplorer: web service for visualizing high-throughput expression data on biological pathways. Nucleic Acids Res (2005) 2.12
Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesis. Cell (2011) 2.11
Mass spectrometry-based functional proteomics: from molecular machines to protein networks. Nat Methods (2007) 2.06
Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer. Gastroenterology (2009) 2.01
c-Src-mediated phosphorylation of hnRNP K drives translational activation of specifically silenced mRNAs. Mol Cell Biol (2002) 1.98
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3. Ophthalmology (2003) 1.96
Autoinhibition of c-Abl. Cell (2002) 1.93
Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics (2007) 1.90
Viral immune modulators perturb the human molecular network by common and unique strategies. Nature (2012) 1.86
Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med (2011) 1.78
BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia. Nat Chem Biol (2012) 1.77
The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J (2008) 1.76
Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3. Arch Ophthalmol (2002) 1.71
Sequence of early vascular events after photodynamic therapy. Invest Ophthalmol Vis Sci (2003) 1.69
A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer. Nat Chem Biol (2011) 1.65
Src kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppression. EMBO J (2006) 1.64
CD14 is a coreceptor of Toll-like receptors 7 and 9. J Exp Med (2010) 1.64
Polarization sensitive optical coherence tomography in the human eye. Prog Retin Eye Res (2011) 1.63
Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib. Leuk Lymphoma (2008) 1.63
Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab. Invest Ophthalmol Vis Sci (2008) 1.62
SAMHD1 is a nucleic-acid binding protein that is mislocalized due to aicardi-goutières syndrome-associated mutations. Hum Mutat (2012) 1.61
Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefes Arch Clin Exp Ophthalmol (2002) 1.61
Effect of retinal photocoagulation on intraretinal lipid exudates in diabetic macular edema documented by optical coherence tomography. Ophthalmology (2010) 1.60
[The Club of Female Professors of the Medical University Vienna]. Wien Med Wochenschr (2009) 1.60
Structural basis for viral 5'-PPP-RNA recognition by human IFIT proteins. Nature (2013) 1.58
Evolution of genomic instability in diethylnitrosamine-induced hepatocarcinogenesis in mice. Hepatology (2011) 1.56
Ultrahigh resolution optical coherence tomography of macular holes. Retina (2006) 1.53
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5. Arch Ophthalmol (2002) 1.53
Human macula investigated in vivo with polarization-sensitive optical coherence tomography. Invest Ophthalmol Vis Sci (2006) 1.52
Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology (2009) 1.52
VennMaster: area-proportional Euler diagrams for functional GO analysis of microarrays. BMC Bioinformatics (2008) 1.49
Diabetic cataract-pathogenesis, epidemiology and treatment. J Ophthalmol (2010) 1.48
A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain. Nat Struct Mol Biol (2010) 1.47
Selective serotonin reuptake inhibitors--a new modality for the treatment of lymphoma/leukaemia? Biochem Pharmacol (2007) 1.44
Preserved cognition after deep brain stimulation (DBS) in the subthalamic area for Parkinson's disease: a case report. Acta Neurochir (Wien) (2010) 1.42
c-Abl is an effector of Src for growth factor-induced c-myc expression and DNA synthesis. EMBO J (2002) 1.41
The role of the optical coherence tomography in identifying shape and size of idiopathic epiretinal membranes. Br J Ophthalmol (2012) 1.41
Proteomic analysis of seminal plasma from infertile patients with oligoasthenoteratozoospermia due to oxidative stress and comparison with fertile volunteers. Fertil Steril (2013) 1.41
Charting the molecular network of the drug target Bcr-Abl. Proc Natl Acad Sci U S A (2009) 1.37
Identification of small gains and losses in single cells after whole genome amplification on tiling oligo arrays. Nucleic Acids Res (2009) 1.37
Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy. Genome Biol (2015) 1.35